Contrasting membrane localization and behavior of halogenated cyclobutanes that follow or violate the Meyer-Overton hypothesis of general anesthetic potency  by North, C. & Cafiso, D.S.
Biophysical Joumal Volume 72 April 1997 1754-1761
Contrasting Membrane Localization and Behavior of Halogenated
Cyclobutanes that Follow or Violate the Meyer-Overton Hypothesis of
General Anesthetic Potency
Christopher North and David S. Cafiso
Department of Chemistry and Biophysics Program at the University of Virginia, Charlottesville, Virginia 22901 USA
ABSTRACT The membrane localization and properties of two halogenated cyclobutanes were examined using 2H and 19F
NMR. The common predictors of potency indicate that these two compounds will have anesthetic activity; however,
1,2-dichlorohexafluorocyclobutane (c(CCIFCCIFCF2CF2)) is not an effective anesthetic, whereas 1-chloro-1,2,2-trifluorocy-
clobutane (c(CCIFCF2CH2CH2)) is an effective general anesthetic. Using 2H NMR, the effect of these compounds on the acyl
chain packing in palmitoyl (d31) oleoylphosphatidylcholine membranes was examined. The addition of the anesthetic
c(CCIFCF2CH2CH2) results in small increases in the segmental order near the headgroup, whereas segments deeper in the
bilayer show decreases in order. These results are consistent with those obtained previously for halothane, isoflurane, and
enflurane. On the addition of the nonanesthetic c(CCIFCCIFCF2CF2), the segmental order is virtually unchanged, except for
a slightly changed order near the segments 10-12 of the palmitoyl chains. These results, and the 19F chemical shifts, indicate
that the anesthetic c(CCIFCF2CH2CH2) exhibits a preference for the membrane interface, as do the other general anesthetics,
whereas the nonanesthetic c(CCIFCCIFCF2CF2) resides within the membrane hydrocarbon core. The compound
c(CCIFCCIFCF2CF2) and other nonanesthetic halocarbons have lower molecular dipole moments compared to effective
anesthetic halocarbons, which may account for their altered distribution within the membrane. These data strongly suggest
that preferential localization of a halocarbon within the membrane interface is a predictor of anesthetic potency. Furthermore,
the data indicate that the properties and forces in the membrane interface deserve consideration as mediators of anesthetic
activity.
INTRODUCTION
For many years the Meyer-Overton rule has been used as a
general predictor of anesthetic potency. Meyer and Overton
noticed that anesthetics had no consistent structural speci-
ficity, but found that potency was correlated with hydrocar-
bon solubility, as measured by partitioning into olive oil
(Meyer, 1899). The Meyer-Overton rule works well for a
wide range of anesthetics and anesthetic potencies, and it is
consistent with the anesthetic "cutoff' in long-chain alco-
hols (Miller, 1985). The Meyer-Overton rule suggests that
the site of anesthetic activity is a hydrophobic but structur-
ally nonspecific site, such as the membrane hydrocarbon.
Indeed, mechanisms involving an anesthetic modification in
the biophysical properties of the membranes have been
proposed, including changes in bilayer curvature (Gruner
and Shyamsunder, 1991) and modulation of membrane
electrostatic properties (Qin et al., 1995). It has also been
proposed that anesthetics are brought into the proximity of
membrane proteins because of their partitioning into the
bilayer, but that they bind directly to membrane proteins at
specific sites to affect activity through allosteric mecha-
nisms (Eyring et al., 1973; Franks et al., 1990). Not enough
is known about how membrane protein function is modified
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by anesthetics at a molecular level to provide conclusive
support for either a membrane or protein site as the primary
anesthetic target.
To gain an increased understanding of the target and
physical mechanisms of anesthesia, compounds have been
sought that violate the conventional predictors of anesthetic
potency. Recently a series of halogenated and perfluori-
nated compounds was examined for their ability to induce
anesthesia (Koblin et al., 1994). Compounds such as per-
fluorinated cyclobutane (c(CF2)4) and c(CClFCClFCF2CF2)
were not anesthetics at levels predicted by the Meyer-
Overton hypothesis, whereas c(CClFCF2CH2CH2) was. The
most obvious difference between these compounds is that
molecules such as c(CF2)4 are symmetrical and will there-
fore have a much lower molecular dipole moment than
compounds such as c(CClFCF2CH2CH2). Whereas c(CF2)4
and c(CCIFCClFCF2CF2) partition into oil and lipids, they
have a low water solubility and might be expected to prefer
the hydrocarbon core to the interfacial region. Other com-
pounds that lacked anesthetic activity also had low solubil-
ities in aqueous solution. In the case of the compounds
tested, the differences in the behavior of these molecules
apparently were not due to differences in their pharmaco-
kinetics (Koblin et al., 1994).
The membrane localization of small molecules such as
anesthetics can readily be deduced from their effect on the
segmental order along the lipid chain (Boden et al., 1991).
The insertion of a small molecule into the hydrocarbon
decreases the gauche-trans isomer ratio of segments near
the binding site, which is seen as an increase in segmental
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order. At chain segments remote from the binding site, the
gauche-trans isomer ratio increases because of the larger
volume available to the chain segments. This is observed as
a decrease in molecular order. The molecular order is easily
observed in labeled lipids using 2H NMR from a measure-
ment of the residual quadrupolar splitting of a deuterated
chain segment (Seelig and MacDonald, 1987), and this
technique was previously used to investigate the distribution
of the volatile anesthetics halothane, enflurane, and isoflu-
rane within membranes (Baber et al., 1995). These anes-
thetics increase molecular order in segments near the inter-
face and lower it in the center of the hydrocarbon, indicating
that these general anesthetics exhibit a preference for the
membrane interface.
In this paper the biophysical properties and membrane
localization of two related polyhalogenated cyclobutanes
(Fig. 1, I and II) are compared. Although they both strongly
partition into membranes, the compound 1-chloro-1,2,2-
trifluoro-cyclobutane (c(CClFCF2CH2CH2) or I) is an ef-
fective anesthetic, whereas 1,2-dichloro-hexaflourocyclobu-
tane (c(CClFCClFCF2CF2) or II) is not. The effects of these
compounds on the dynamics of the palmitoyl chains in a
palmitoyl(d3l)oleoyl-phosphatidylcholine (POPC) disper-
sion are examined using 2H NMR. The 19F chemical shifts
of these compounds are also examined in various environ-
ments, along with the general anesthetics halothane and
isoflurane. The data indicate dramatic and clear differences
in the membrane localization of the anesthetic versus non-
anesthetic compound. These differences further suggest ex-
planations for the violation of the Meyer-Overton hypothe-
sis by these compounds and improved predictors of
anesthetic action.
EXPERIMENTAL
Materials
Deuterated P(d31)OPC and unlabeled POPC were obtained from Avanti
Polar Lipids (Birmingham, AL), and dimyristoylphosphatidylcholine
(DMPC) was obtained from Sigma (St. Louis, MO). These lipids were used
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FIGURE 1 Structures of the anesthetic and nonanesthetic cyclobutanes.
The partially substituted halogenated cyclobutane I is a good anesthetic,
whereas the fully halogenated cyclobutane II is not (Koblin et al., 1994).
without further purification. The anesthetic halothane (2-bromo-2-chloro-
1,1,1-trifluoroethane) was obtained from Halocarbon Laboratories (Hack-
ensack, NJ), and isoflurane (1
-chloro-2,2,2-trifluoroethydifluoromethyl
ether) was obtained from Anaquest (Madison, WI). The compounds
1-chloro- 1 ,2,2-triflouro-cyclobutane (I) and 1 ,2-dichlorohexafluoro-cy-
clobutane (II) were obtained from PCR (Gainesville, FL).
METHODS
Deuterium NMR of membranes
Labeled and unlabeled POPC were mixed in a roughly 50/50 proportion to
maximize sample size and optimize the signal within the dynamic range of
the NMR receiver. POPC in CH3C1 was evaporated to dryness and then
placed under vacuum overnight. The dry powdered POPC was placed into
quartz sample tubes, and deionized water or buffer (100 mM NaCl, 10mM
3-(N-morpholino)propanesulfonic acid, pH 7) was injected into the sample
at a level of 50% by weight. Samples were stirred with a microspatula and
then gently centrifuged to alternate ends of the sample tube to promote
mixing between freeze thaw cycles. The sample was taken through at least
five freeze-thaw cycles to ensure homogeneity. Anesthetics and haloge-
nated compounds were injected directly into the sample using microliter
syringes, and the quantities of the compounds added were confirmed
gravimetrically. These samples were sealed, allowed to equilibrate over-
night, and again mixed by centrifugation before data acquisition.
The 2H NMR spectra were measured at 55 MHz with a highly modified
Nicolet NT-360 spectrometer at 35°C, using a quadrupolar echo sequence,
a sweep width of 100,000 Hz, a 2.2-,s pulse length, and a 200-ms recycle
delay. Each spectrum was the sum of 12,000 acquisitions. Quadrupolar
splittings were determined from the highest points of the o, peaks, and
resonances were assigned by taking the innermost CD3 segment to be
represented by the smallest splitting and assigning increasing splittings to
outer segments in order. Assignment of the resonances from inside to
outside assumes a steady progression of higher order from the end of the
acyl chain, as has been demonstrated previously (Seelig and Seelig, 1974).
Relative order parameters were calculated from the ratios of the splittings
for a given sample relative to a reference sample with no anesthetic present.
19F NMR of anesthetics
Fluorine 19 spectra at 470 MHz were taken on a GE Omega 500 NMR
spectrometer for the anesthetics halothane, isoflurane, I, and the nonanes-
thetic halogenated cyclobutane II at 1% v/v in the following solvent
environments: H20, hexanes (predominately n-hexane), n-decane, and 0.1
,um diameter-extruded DMPC vesicles in H20 (1:4 w/w). The concentra-
tion of II in H20 was 0.3%, so that signals from suspensions of undissolved
II would be eliminated. The NMR spectra were the average of 64 acqui-
sitions, except the spectrum for II in H20, which is an average of 4096
acquisitions. Isoflurane was further examined in a number of solvents of
varying dielectrics. A single pulse was used without proton decoupling at
350C. Chemical shift references are relative to the center of CF3 of external
neat trifluoroethanol.
RESULTS
Compound I prefers the membrane interface, as
do other volatile anesthetics
Shown in Fig. 2 is a series of 2H NMR spectra for labeled
P(d3l)OPC in the absence and presence of the anesthetic I.
The spectra in the absence of anesthetic are similar to those
reported by Baber et al. (1995), with segments 2-8 showing
up under a single broad resonance. Upon the addition of I,
the residual quadrupolar coupling for segments 2- 8 exhibits
a slight increase, corresponding to an increase in segmental
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order, whereas the residual quadrupolar coupling for seg-
ments deeper in the membrane hydrocarbon decreases upon
the addition of anesthetic. Fig. 3 shows the relative order
parameters for this lipid upon the addition of anesthetic.
Also shown for comparison is the relative order parameter
profile for P(d31)OPC in the presence of isoflurane obtained
previously (Baber et al., 1995). It can be seen that the profile
for the cyclobutane anesthetic is similar to that obtained
previously for isoflurane and consistent with the profiles
obtained for other inhalation anesthetics.
The relative changes in molecular chain order seen in Fig.
3 indicate an increase in gauche-trans isomer ratio for
deeper segments in the membrane, resulting in a shortening
of these segments of the chain. This decrease in chain length
is a result of the lateral expansion of the chains produced by
binding of anesthetic near the interface. From the segmental
order parameters, SCD(i), an estimate of the average length
of any acyl chain segment can be obtained from
(L = n- + i)
- E SCD(i) - 3SCD(n) , (1)
18 12 6 0 -6 -12
kHz
FIGURE 2 2H NMR spectra for P(d3,)OPC in the presence of the
halogenated cyclobutane I. Concentrations of I in POPC are 0, 24, 35, 44,
49, 56 mol% (top to bottom).
1.1
1.05
where (L) is the chain length projected along the bilayer
normal, I = 1.25 A is the projected length of a trans
segment, and m and n are the first and last segments con-
sidered, respectively (Salmon et al., 1987, Seelig and
Seelig, 1974). Using a formalism presented previously
(Baber et al., 1995, Seelig and Seelig, 1974, Seelig and
Macdonald, 1987), we used a simple two-site model to
analyze the values of SCD in terms of the membrane distri-
bution of anesthetic. The acyl chains are treated as a cylin-
FIGURE 3 Relative order parameter (SCD) for P(d3 )OPC
as a function of the segment position in the presence of I or
isoflurane (the isoflurane data were obtained previously;
Baber et al., 1995). Mole fractions in POPC: *, 0.24 of I; A,
0.30 of I; *, 0.49 of I; 0, 0.24 of isoflurane. The deuterium
spectra for compound I are overlapped for positions 2-7,
and the value at position 7 represents the value for these
segments.
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der, and the average cross-sectional area (A) is estimated
from
V(A) = (L)1 (2)
where V is the volume of a methylene segment in the liquid
crystalline state. We assume two sites for anesthetic bind-
ing, one from segments 1-7 and another from segments
8-16. In the presence of even high concentrations of I, the
changes in the lengths of the hydrocarbon segments are
quite small. For I at a concentration of X = 0.49, the length
of the site from segments 8 to 16 decreases by 0.16 A,
whereas the length of the site from segments 1 to 7 increases
by just 0.04 A. From these data one finds an average
increase in the lateral area of the palmitoyl chain of 1.0 A2,
which corresponds to an average volume increase of 6.12
A3 per lipid chain. This is the volume that would be avail-
able for solute occupation in the site from segments 1 to 7.
Assuming that the oleoyl chain is similarly affected and that
all of the anesthetic is bound inside of the first hydrocarbon
segment, one obtains a fractional occupation of FI = 0.53
for the region adjacent to segments 1-7 relative to segments
8-16 (a detailed discussion of this analysis can be found
elsewhere; Baber et al., 1995). This result is comparable to
previous findings, where a slight preference for occupancy
in the interfacial region was obtained for halogenated gen-
eral anesthetics (Baber et al., 1995). However, as discussed
below, this value of FI could easily be an underestimate, and
the fraction of anesthetic localized near the interface may be
higher than that reported here.
The nonanesthetic 11 localizes within the
membrane hydrocarbon interior
Shown in Fig. 4 is a series of 2H NMR spectra for labeled
POPC in the presence of the nonanesthetic II, and Fig. 5
shows the relative order parameters for this compound
plotted as a function of segment position. In contrast to the
anesthetics previously examined, the splittings and order
parameters are nearly unchanged as the concentration of II
is increased. The relative order parameters show a slight
increase along the chain as the concentration of this com-
pound is increased, with the highest increase in order pa-
rameters occurring in the vicinity of CIO to C12. This sug-
gests that compound II is very evenly distributed in the
hydrocarbon region of the lipids, with just a slight prefer-
ence for localization near C1O to C12. The acyl chains of the
bilayer require relatively little change in dynamics to ac-
commodate this substituted nonanesthetic cyclobutane.
Fluorine-19 chemical shifts indicate an interfacial
location for anesthetics
The 19F chemical shifts of the two halogenated cyclobu-
tanes, along with the inhalation anesthetics isoflurane and
halothane, were examined in environments of varied dielec-
K)
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FIGURE 4 2H NMR spectra for P(d3)OPC in the presence of the
perhalogenated cyclobutane II. Concentrations of II in POPC are 0, 11, 22,
35, 41, 47, 55 mol% (top to bottom).
tric and compared with the chemical shifts in unilamellar
lipid vesicles. The concentrations of lipid used in these
samples is high enough that all of the anesthetic will be
associated with the membrane phase. Under these condi-
tions, the observed chemical shift should provide an approx-
imate indication of the relative dielectric of the environment
around the anesthetic. And because there is a gradient of the
dielectric within the bilayer, this chemical shift will provide
a relative indication of position. If anesthetic is exchanging
in several domains (for example, the membrane interface
and the hydrocarbon domain), a time average-weighted
chemical shift intermediate to these environments will be
indicated (provided that the exchange of the compound is
fast on the NMR chemical shift time scale).
Shown in Fig. 6 is a series of 19F NMR spectra taken for
halothane at a frequency of 470 MHz. Halothane shows a
single 19F resonance at this frequency, where the chemical
shift exhibits a 0.81 ppm difference between a 1% solution
in H20 and 1% in hexanes. The peak of the 19F resonance
in DMPC is about 0.04 ppm upfield from the aqueous
resonance. These data indicate that in DMPC halothane
experiences an environment that is on average closer to that
of water than bulk hydrocarbon.
North and Cafiso 1 757
Kk1
Volume 72 April 1997
1.1 r
1.05 |
a)
a)
o
E
CZ
a)
G
0
U)
(U
1
0.95 -
0.9 [
0.85 [
A
v60-6
5.0
8 10 12
Segment Position
0.0
14 16
FIGURE 5 Relative order parameter (SCD) for P(d3,)OPC as a function
of the segment position in the presence of II. Mole fractions in POPC: *,
0.1 1; 0, 0.18 mol; A, 0.22; A, 0.35. The deuterium spectra for compound
II are overlapped for positions 2-8, and the value at position 8 represents
the value for these segments.
The 19F NMR spectra for isoflurane are shown in Fig. 7.
There is a singlet downfield representing the three equiva-
lent CF3 nuclei, and a resonance upfield from CHF2. In
water, the CHF2 resonance is a doublet, indicating that
equivalent fluorines are being split by the attached proton.
In low dielectric solvents, the CHF2 resonance appears as a
quadruplet of doublets. The splitting by the proton is re-
tained, whereas the fluorines become distinct and have
different chemical shifts on the order of the scalar cou-
plings, which are also expressed. This results in the qua-
druplet, which has splittings that can fit to a smooth function
ppm
FIGURE 6 Fluorine-19 NMR spectra of halothane (1% by volume) in
hexanes, H20, and 0.1-,um-diameter DMPC vesicles (-200 mg lipid/ml)
(top to bottom).
-5.0
ppm
-10.0
FIGURE 7 Fluorine-19 NMR spectra of isoflurane (1% by volume) in
hexanes, H20, and 0.1-,um-diameter DMPC vesicles (-200 mg lipid/ml)
(top to bottom).
of the dielectric constant for 1% solutions in several sol-
vents (spectra not shown).
The CF3 peak is shifted upfield in hexane by 0.71 ppm
compared to H20. In the DMPC/H20 sample at 35°C the
signal is a peak between the water and n-hexane chemical
shift positions near the aqueous signal. The multiplet from
CHF2 is also dramatically broadened and shifted downfield
of both the aqueous and oil chemical shifts. The appearance
of the CHF2 19F resonance is dramatically dependent on the
solvent environment, and the observed broadening is likely
due to exchange between differing environments. These
spectra indicate that isoflurane resides in membranes in an
environment that is intermediate between that of a pure
hydrocarbon and an aqueous phase with a time-averaged
position in a more aqueous environment.
Shown in Fig. 8 are the 19F NMR spectra of I, which
shows three resonances in all solvents: a single peak from
CFCI and two doublets from the CF2, which are distinct
because of the relative cis or trans position of Cl. The CF2
resonances are each split by 193 Hz by the other fluorine.
The signals in hexane are shifted upfield relative to water by
0.28 and 0.48 ppm for the two fluorines on CF2 and 0.125
ppm for the CFCI resonance. The peak of the resonance in
DMPC is nearer to the aqueous chemical shift and down-
field by 0.05, 0.28, and 0.25 ppm for the two fluorines on
CF2 and CFCI, respectively, suggesting that I spends most
of its time in an environment near that of water.
Fluorine 19 chemical shifts indicate an
hydrocarbon location for 11
As shown in Fig. 9, two singlets and four doublets are
observed for nonanesthetic II in H20, hexane and in DMPC
dispersion. Some fluorines should be equivalent; however,
cis and trans isomers are present, and the number of signals
is due to the two chiral centers. Within each population
..
n-.
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FIGURE 8 Fluorine-19 NMR spectra of I (1% by volume) in hexanes,
H20, and 0.1-,um-diameter DMPC vesicles ( 200 mg lipid/ml) (top to
bottom).
there are three pairs of equivalent fluorines exhibiting three
signals each from two populations, with the chlorines being
cis or trans. There are chemical shift differences for the
doublets between the water and hexane samples of 0.64-
0.93 ppm upfield. The singlets show chemical shift differ-
ences of 0.24 and 0.35 ppm between aqueous and oil phases.
The signals for II in DMPC vesicles are more than half of
the way toward the shifts in hexane. Thus, in contrast to the
anesthetics, the nonanesthetic II yields a chemical shift in
DMPC dispersions that is closer to that found for the com-
pound in oil than in water.
DISCUSSION
The partially substituted halogenated cyclobutane I is
known to act as an anesthetic (Koblin et al., 1994), and it is
shown here to have effects on membrane chain dynamics
and packing similar to those found previously for clinically
relevant inhalation anesthetics (Baber et al., 1995). The
differential effects on molecular order along the length of
-32.0 -40.0 -48.0 -56.0 -64.0
ppm
FIGURE 9 Fluorine-19 NMR spectra of 1% by volume II in hexanes,
0.3% in H20, and 1% in 0.1-,um-diameter DMPC vesicles ( 200 mg
lipid/ml) (top to bottom).
the lipid hydrocarbon chain indicate a preferential partition-
ing for all of these anesthetic compounds into the membrane
interface.
As described above, I exhibits a fractional partitioning
into the region adjacent to segments 1-7 of the palmitoyl
chain of FI = 0.53 at a minimum, indicating a preference for
spending time near the interface. It is important to point out
that this number is based on several simplifying assump-
tions that could underestimate the occupation of anesthetic
in the interfacial domain. This estimate of the fractional
occupation due to the volume expansion produced by the
anesthetic was assumed to occur entirely in the interfacial
hydrocarbon region C1-C7 (Baber et al., 1995). This may
not be the case if the anesthetic occupies volume near the
glycerol backbone or headgroup regions. If the lateral area
equal to that in segments 1-7 occupied by anesthetic ex-
tends through the headgroup region, -30 A3 of additional
volume could be occupied by anesthetic. In this case, the
fractional occupation for the region on the aqueous side of
acyl segment 7 would be FI = 0.62. Furthermore, it has
been suggested that anesthetics displace some water in the
interface (Ueda et al., 1986). If one water molecule per lipid
were displaced by anesthetic, its fractional occupation in the
interface region could be as high as 70%. Thus for I as well
as for halothane, isoflurane, and enflurane, the fractional
occupation of these anesthetics in an interfacial domain
could be higher than previously estimated (Baber et al.,
1995), and twice as much anesthetic may reside in the
interfacial region as in the hydrocarbon core.
The 19F chemical shifts of c(CClFCF2CH2CH2), halo-
thane, and isoflurane when bound to membranes more
closely resemble that in an aqueous environment than shifts
in a hydrocarbon environment, also indicating a preference
of the anesthetics for the interfacial domain. The chemical
shifts of 19F in halothane were previously shown to correlate
with a parameter related to dielectric, the Hildebrand 6, and
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could be used to examine the binding of anesthetics to lipids
(Koehler et al., 1977, 1980). In contrast, the nonanesthetic II
is only slightly soluble in aqueous solvents, and the 19F
spectrum of II in DMPC dispersions closely resembles the
spectrum observed in hexane. Furthermore, the uniform
profile of relative order parameters (Fig. 5) suggests that
this compound partitions throughout the bilayer interior
with a small preference for the region near segments 10-12
of the palmitoyl chain of POPC. The fully substituted cy-
clobutane II actually slightly "stiffens" the interior of the
bilayer because of its preferential partitioning into the
hydrocarbon.
The data shown here provide a strong indication that
effective anesthetics must reside preferentially in the mem-
brane interfacial region. At the present time, the role, if any,
for anesthetic localization in the interface is not understood.
It has been suggested that anesthetics act by directly inter-
acting with membrane proteins. In this case, localization in
the interface, although a reflection of the properties of
anesthetics, might otherwise be of no more direct conse-
quence for anesthesia other than to increase the concentra-
tion near a binding site. On the other hand, the physical
properties of the membrane interface are known to be im-
portant for membrane-protein function, and the conse-
quences of anesthetics in this region could well account for
anesthesia. For example, anesthetics appear to alter the
membrane dipole potential, a feature that is likely associated
with localization in the interface (Qin et al., 1995). Dipole
potentials are altered by about 10 mV at clinical levels of
anesthetics, a change that could modulate the activity of
proteins exhibiting electrically active conformational tran-
sitions. The localization of anesthetics in the interface
should also change the interfacial tension or spontaneous
radius of curvature of the lipid interface (Gruner and Shy-
amsunder, 1991). It is well documented that changes in the
spontaneous curvature of the membrane lipid can alter the
activity of channels such as alamethicin (Gruner and Shy-
amsunder, 1991; Keller and Gruner, 1996). G-protein cou-
pled receptors such as rhodopsin also appear to be sensitive
to lipid compositions that alter lateral forces in the mem-
brane interface (Baldwin and Hubbell, 1985; Brown, 1994;
Cline and Cafiso, 1986).
The molecular dipoles of the anesthetic compounds halo-
thane, isoflurane, and I were modeled using BIOSYM/MSI
Insight II software along with a number of nonanesthetic
molecules. The range of dipole moments obtained is shown
in Table 1 along with a mean dipole moment. The range and
magnitude of the molecular dipole moments clearly corre-
late with anesthetic potency previously reported (Koblin et
al., 1994) and with interfacial localization. The dipole mo-
ments for the anesthetics are found to be variable over a
relatively wide range, depending on the conformation of the
molecule, and this variability may allow these compounds
to interact favorably in environments of varying polarity. A
low molecular dipole moment is common to the compounds
that violate the Meyer-Overton rule tested previously (Kob-
lin et al., 1994). As seen in Table 1, the molecular dipoles
TABLE I Molecular dipole moments (in Debye units) of
anesthetics and nonanesthetics*
Minimum Maximum Mean
Compound dipole dipole dipole ± SD
Halothane 0.54 3.4 2.26 ± 0.36
Isoflurane 0.35 5.0 2.98 + 1.02
CTFCB 1.66 4.3 3.05 ± 0.38
cis-DCHFCB 0.27 1.2 0.48 ± 0.20
trans-DCHFCB 0.05 1.4 0.52 + 0.21
CC12F2 0.27 0.46 0.23 + 0.09
CCIF2CF3 0.13 1.2 0.54 + 0.22
(CCIF2)2 0.04 0.71 0.32 + 0.13
CF3CCIFCF3 0.12 1.5 0.63 + 0.25
CF3(CCIF)2CF3 0.59 1.4 0.64 + 0.26
CBr2F2 0.04 1.0 0.39 + 0.20
CBrF2CF3 0.11 1.2 0.52 + 0.28
CF3CBrFCF3 0.08 1.1 0.54 + 0.22
*Dipole moments were calculated using the BIOSYM/MSI Insight II
software package. The first three molecules in this list are anesthetics. The
minimum and maximum values for the dipole moments were obtained
from conformations encountered during a molecular dynamics simulation.
Simulations were run using the ESFF forcefield provided with Discover
95.0/3.00 for a single molecule in vacuum at 300K for 500 ps after 100 ps
of equilibration.
of these compounds are uniformly small, and there is much
less variability due to molecular dynamics than in the an-
esthetic molecules. This may explain why molecules such as
II partition deep into the bilayer.
The results obtained here are in agreement with the
results of recent modeling calculations (Pohorille et al.,
1996). In this study, molecular dynamics was used to de-
termine the free energy profile of the anesthetic trifluoro-
ethane and nonanesthetic perfluoroethane in passing from
the bulk aqueous phase to the interior of a glycerol mo-
nooleate model membrane. It was found that the anesthetic
had an energy minimum just inside the interface and a local
minimum in the headgroup region. The perfluorinated non-
anesthetic had a broad minimum throughout the membrane
interior.
In conclusion, the results obtained here reveal a remark-
ably different behavior for anesthetic versus nonanesthetic
halogenated cyclobutanes in membranes. The anesthetic
compound chlorotrifluorocyclobutane (I) is distributed
throughout the bilayer, but preferentially resides in the
interfacial domain. The effects of this compound on mem-
branes and its localization are consistent with that observed
for other inhalation anesthetics. The nonanesthetic dichlo-
rohexafluorocyclobutane (II) resides deep within the bilayer
interior and does not demonstrate an affinity for the mem-
brane interface. Thus anesthetic potency is not simply indi-
cated by lipophilicity, as suggested by Meyer and Overton,
but is indicated by the ability to partition into the interfacial
region of the bilayer. For this to occur, the compounds must
be hydrophobic, but have some dipolar character (either
permanent or inducible).
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